We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$78.9B
AUM Growth
+$522M
Cap. Flow
+$1.98B
Cap. Flow %
2.5%
Top 10 Hldgs %
13.37%
Holding
702
New
56
Increased
268
Reduced
333
Closed
31

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$552M
2
BA icon
Boeing
BA
+$226M
3
ORCL icon
Oracle
ORCL
+$190M
4
CB icon
Chubb
CB
+$176M
5
NVS icon
Novartis
NVS
+$172M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Industrials 14.85%
3 Technology 14.38%
4 Healthcare 14.3%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIVB
526
DELISTED
SVB Financial Group
SIVB
$962K ﹤0.01%
1,711
-557
-25% -$323K
PRDO icon
527
Perdoceo Education
PRDO
$1.99B
$946K ﹤0.01%
89,626
-5,523
-6% -$62.2K
SMCI icon
528
Super Micro Computer
SMCI
$19.3B
$946K ﹤0.01%
258,780
-37,280
-13% -$135K
BV icon
529
BrightView Holdings
BV
$1.33B
$937K ﹤0.01%
63,499
+905
+1% +$13.8K
SP
530
DELISTED
SP Plus Corporation
SP
$929K ﹤0.01%
30,277
-16,703
-36% -$518K
NBN icon
531
Northeast Bank
NBN
$1.14B
$907K ﹤0.01%
26,893
-4,228
-14% -$135K
XEC
532
DELISTED
CIMAREX ENERGY CO
XEC
$899K ﹤0.01%
+10,307
New +$716K
ACBI
533
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$895K ﹤0.01%
33,784
-5,312
-14% -$130K
COWN
534
DELISTED
Cowen Inc. Class A Common Stock
COWN
$884K ﹤0.01%
25,777
-4,053
-14% -$152K
RMR icon
535
The RMR Group
RMR
$348M
$878K ﹤0.01%
26,240
-20,711
-44% -$788K
PKX icon
536
POSCO
PKX
$16.1B
$876K ﹤0.01%
12,704
-267
-2% -$19.7K
NTUS
537
DELISTED
Natus Medical Inc
NTUS
$874K ﹤0.01%
34,857
-4,186
-11% -$107K
TX icon
538
Ternium
TX
$9.37B
$873K ﹤0.01%
20,641
-2,973
-13% -$145K
HROW icon
539
Harrow
HROW
$1.4B
$869K ﹤0.01%
95,639
-32,394
-25% -$293K
BNED icon
540
Barnes & Noble Education
BNED
$445M
$868K ﹤0.01%
868
-375
-30% -$331K
UVE icon
541
Universal Insurance Holdings
UVE
$1.21B
$857K ﹤0.01%
65,713
+24,607
+60% +$336K
ENVA icon
542
Enova International
ENVA
$6.27B
$854K ﹤0.01%
24,706
-8,477
-26% -$277K
ZIM icon
543
ZIM Integrated Shipping Services
ZIM
$2.96B
$842K ﹤0.01%
+16,601
New +$775K
VIRT icon
544
Virtu Financial
VIRT
$5.12B
$841K ﹤0.01%
34,420
+4,405
+15% +$112K
SPG icon
545
Simon Property Group
SPG
$75.1B
$834K ﹤0.01%
6,417
-925
-13% -$120K
ULCC icon
546
Frontier Group Holdings
ULCC
$1.4B
$834K ﹤0.01%
52,837
-4,213
-7% -$65K
CURO
547
DELISTED
CURO Group Holdings Corp.
CURO
$815K ﹤0.01%
47,030
-4,840
-9% -$79.6K
INN
548
Summit Hotel Properties
INN
$748M
$813K ﹤0.01%
84,444
-13,277
-14% -$122K
MRTN icon
549
Marten Transport
MRTN
$1.26B
$811K ﹤0.01%
51,715
-8,087
-14% -$127K
RDS.B
550
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$807K ﹤0.01%
18,239

Similar funds

Boston Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Boston Partners held 702 positions worth $78.9B, up 0.67% from $78.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q3 2021 filing shows 56 new, 268 increased, 333 reduced and 31 closed positions. Its largest new stake was Global Payments: 2,796,841 shares worth $441M. The largest sale was Elevance Health, an estimated $552M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • Boston Partners's largest Q3 2021 buy was Global Payments: 2,796,841 shares worth $441M.
  • Boston Partners added most to Activision Blizzard in Q3 2021, an estimated $314M increase.
  • Boston Partners's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $552M.
  • Boston Partners fully exited Cummins in Q3 2021, selling an estimated $161M.
  • Boston Partners's ten largest holdings make up 13% of its $78.9B portfolio in Q3 2021.
  • Boston Partners opened 56 new positions and closed 31 in Q3 2021.
  • Boston Partners's portfolio value rose 0.67% quarter-over-quarter to $78.9B.

Based on Boston Partners's 13F filing for Q3 2021, filed 5 Nov 2021.